CAH vs MCK
Cardinal Health Inc. and Mckesson Corp., side by side — 10 fiscal years reported in USD, drawn from SEC filings.
At a glance
Most recent reported year
| Metric | CAH | MCK |
|---|---|---|
| Revenue | $254.2B | $403.4B |
| Net income | $1.7B | $4.8B |
| Gross margin | 3.8% | 3.6% |
| Net margin | 0.7% | 1.3% |
| Return on equity | — | — |
| Diluted EPS | $7.23 | $38.38 |
| Dividend / share | $2.04 | $3.17 |
| Payout ratio | 28.6% | 8.0% |
| Free cash flow | $4.5B | $5.7B |
| Equity | $-2.9B | $-2.2B |
| Net debt / equity | — | — |
| Current ratio | 0.88× | 0.85× |
| Revenue CAGR 5y | 9.4% | 11.1% |
| Profit CAGR 5y | 22.9% | — |
MCK bills 1.6× the revenue of CAH, and keeps more of each dollar of revenue as profit (1.3% against 0.7%).
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner.
Revenue by year
10 years side by side
| Fiscal year | CAH | MCK |
|---|---|---|
| FY2025 | $254.2B | $403.4B |
| FY2024 | $222.6B | $359.1B |
| FY2023 | $226.8B | $309.0B |
| FY2022 | $205.0B | $276.7B |
| FY2021 | $181.3B | $264.0B |
| FY2020 | $162.5B | $238.2B |
| FY2019 | $152.9B | $231.1B |
| FY2018 | $145.5B | $214.3B |
| FY2017 | $136.8B | $208.4B |
| FY2016 | $130.0B | $198.5B |
Net income by year
Bottom line
| Fiscal year | CAH | MCK |
|---|---|---|
| FY2025 | $1.7B | $4.8B |
| FY2024 | $1.6B | $3.3B |
| FY2023 | $852.0M | $3.0B |
| FY2022 | $330.0M | $3.6B |
| FY2021 | $-938.0M | $1.1B |
| FY2020 | $611.0M | $-4.5B |
| FY2019 | $-3.7B | $900.0M |
| FY2018 | $1.4B | $34.0M |
| FY2017 | $256.0M | $67.0M |
| FY2016 | $1.3B | $5.1B |